Literature DB >> 16325915

The diagnosis of manganese-induced parkinsonism.

Maria G Cersosimo1, William C Koller.   

Abstract

Parkinsonism is a clinical syndrome consisting of tremor, bradykinesia, rigidity, gait, balance problems, in addition to various non-motor symptoms. There are many causes of parkinsonism such as neurodegenerative disease, drugs, vascular causes, structural lesions, infections, and toxicants. Parkinson's disease, or idiopathic parkinsonism, is the most common form of parkinsonism observed in the clinic. There is degeneration of the substantia nigra, pars compacta, which results in loss of striatal dopamine. Parkinson's disease is a slowly progressive condition in which there is a dramatic and sustained responsiveness to levodopa therapy. Manganese is an essential trace element that can be associated with neurotoxicity. Hypermanganism can occur in a variety of clinical settings. The clinical symptoms of manganese intoxication include non-specific complaints, neurobehavioral changes, parkinsonism, and dystonia. Although the globus pallidus is the main structure of damage, other basal ganglia areas can also be involved. MRI scans may show globus pallidus changes during (and for a short period after) exposure. Fluorodopa PET scans that assess the integrity of the substantia nigra dopaminergic system are abnormal in Parkinson's disease. However, these scans re-reported to be normal in a few cases studied with manganese-induced parkinsonism. The parkinsonism due to manganese may have some clinical features that occur less commonly in Parkinson's disease, such as kinetic tremor, dystonia, specific gait disturbances, and early mental, balance and speech changes. The clinical signs tend to be bilateral whereas Parkinson's disease begins on one side of the body. Patients with manganese-induced parkinsonism may be younger at the onset of the disease than with Parkinson's disease. Lastly, there appears to be a lack of response to levodopa therapy in manganese-induced parkinsonism. In summary it may be possible to differentiate manganese-induced parkinsonism from Parkinson's disease using clinical and imaging studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325915     DOI: 10.1016/j.neuro.2005.10.006

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  78 in total

1.  Waterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviors.

Authors:  Steve Fordahl; Paula Cooney; Yunping Qiu; Guoxiang Xie; Wei Jia; Keith M Erikson
Journal:  Neurotoxicol Teratol       Date:  2011-10-21       Impact factor: 3.763

2.  X-ray fluorescence imaging of the hippocampal formation after manganese exposure.

Authors:  Gregory Robison; Taisiya Zakharova; Sherleen Fu; Wendy Jiang; Rachael Fulper; Raul Barrea; Wei Zheng; Yulia Pushkar
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

3.  Mechanisms of lead and manganese neurotoxicity.

Authors:  April P Neal; Tomas R Guilarte
Journal:  Toxicol Res (Camb)       Date:  2013-03-01       Impact factor: 3.524

Review 4.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

5.  Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation.

Authors:  Ping Zhang; Tamika A Wong; Kyle M Lokuta; Deanne E Turner; Kristina Vujisic; Bin Liu
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

6.  Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water.

Authors:  Saritha Krishna; Celia A Dodd; Shahryar K Hekmatyar; Nikolay M Filipov
Journal:  Arch Toxicol       Date:  2013-07-06       Impact factor: 5.153

7.  Higher Hippocampal Mean Diffusivity Values in Asymptomatic Welders.

Authors:  Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Lan Kong; Jeff D Yanosky; Richard B Mailman; Xuemei Huang
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

8.  Occupational neurotoxic diseases in taiwan.

Authors:  Chi-Hung Liu; Chu-Yun Huang; Chin-Chang Huang
Journal:  Saf Health Work       Date:  2012-11-30

9.  Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations.

Authors:  Dallas M Cowan; Wei Zheng; Yan Zou; Xiujuan Shi; Jian Chen; Frank S Rosenthal; Qiyuan Fan
Journal:  Neurotoxicology       Date:  2009-02-20       Impact factor: 4.294

10.  Longitudinal T1 relaxation rate (R1) captures changes in short-term Mn exposure in welders.

Authors:  Mechelle M Lewis; Michael R Flynn; Eun-Young Lee; Scott Van Buren; Eric Van Buren; Guangwei Du; Rebecca C Fry; Amy H Herring; Lan Kong; Richard B Mailman; Xuemei Huang
Journal:  Neurotoxicology       Date:  2016-08-24       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.